The natural history of conducting and reporting clinical trials: Interviews with trialists

Trials

Volumn 16, Issue 1, 2015, Pages

  Smyth, Rebecca ^a   Jacoby, Ann ^b   Altman, Douglas G ^c   Gamble, Carrol ^b   Williamson, Paula R ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Equipoise; Interviews; Qualitative; Recruitment; Research reporting; Trial protocols; Trialists

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); EQUIPOISE; HUMAN; OUTCOME VARIABLE; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEW; TELEPHONE INTERVIEW; CLINICAL PROTOCOL; INTERVIEW; METHODOLOGY; PUBLICATION;

CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; HUMANS; INTERVIEWS AS TOPIC; PERIODICALS AS TOPIC; RESEARCH DESIGN;

EID: 84924240125     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-014-0536-6     Document Type: Article

References (56)

1. Altman DG. The scandal of poor medical research. BMJ. 1994;308:283-4.
2. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12.
3. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303:2058-64.
4. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet. 2005;365:1159-62.
5. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010;340:c723.
6. Peron J, Pond GR, Gan HK, Chen EX, Almufti R, Maillet D, et al. Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review. J Natl Cancer Inst. 2012;104:982-9.
7. Farrell B, Kenyon S, Shakur H. Managing clinical trials. Trials. 2010;11:78.
8. Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, et al. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess. 2007;11:iii, ix-105.
9. Duley L, Antman K, Arena J, Avezum A, Blumenthal M, Bosch J, et al. Specific barriers to the conduct of randomized trials. Clin Trials. 2008;5:40-8.
10. Smith A, Palmer S, Johnson DW, Navaneethan S, Valentini M, Strippoli GF. How to conduct a randomized trial. Nephrology (Carlton). 2010;15:740-6.
11. Chalmers I. Underreporting research is scientific misconduct. JAMA. 1990;263:1405-8.
12. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009;1:MR000006.
13. Dickersin K, Chan S, Chalmers TC, Sacks HS, Smith Jr H. Publication bias and clinical trials. Control Clin Trials. 1987;8:343-53.
14. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3:e308.
15. Altman DG, Furberg CD, Grimshaw JM, Rothwell PM. Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials. Trials. 2006;7:6.
16. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ. 2010;340:c365.
17. Smyth RM, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR. Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ. 2011;342:c7153.
18. Richie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analysis qualitative data. London: Routledge; 1994. p. 173-94.
19. Jones AP, Conroy E, Williamson PR, Clarke M, Gamble C. The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. BMC Med Res Methodol. 2013;13:50.
20. Clark M. Standardising outcomes for clinical trials and systematic reviews. Trials. 2007;8:39.
21. Cooney RM, Warren BF, Altman DG, Abreu MT, Travis SP. Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials. 2007;8:17.
22. Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007;8:38.
23. Sinha I, Jones L, Smyth RL, Williamson PR. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med. 2008;5:0569-77.
24. Sinha IP, Gallagher R, Williamson PR, Smyth RL. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012;13:103.
25. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.
26. COMET. [http://www.comet-initiative.org ] (accessed June 2013).
27. Caldwell PHY, Hamilton S, Tan A, Craig JC. Strategies for increasing recruitment to randomised controlled trias: systematic review. PLoS Med. 2010;7:e1000368.
28. Prescott RJ, Counsel CE, Gillepsie WJ, Grant A, Russell IT, Kiauka S, et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess. 1999;3:1-143.
29. Kaur G, Smyth RL, Williamson PR. Developing a survey of barriers and facilitators to recruitment in randomised controlled trials. Trials. 2012;13:218.
30. Raftery J, Kerr C, Hawker S, Powell J. Paying clinicians to join clinical trials: a review of guidelines and interview study with trialists. Trials. 2009;10:15.
31. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7576.
32. World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 2008. [www.wma.net/en/30publications/10policies/b3/index.html ]
33. Pildal J, Chan A-W, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ. 2005;330:1049.
34. Hróbjartsson A, Pildal J, Chan AW, Haahr MT, Altman DG, Gøtzsche PC. Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. J Clin Epidemiol. 2009;62:967-73.
35. Al-Marzouki S, Roberts I, Evans S, Marshall T. Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet. Lancet. 2008;372:201.
36. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200-7.
37. Frank E. Authors' criteria for selecting journals. JAMA. 1994;272:163-4.
38. The PLoS Medicine Editors. Better reporting, better research: guidelines and guidance in PLoS Medicine. PLoS Med. 2008;5:e99.
39. NIHR. [http://www.nets.nihr.ac.uk/news/all/2013/high-publication-rate-for-projects-funded-by-the-nihr-hta-programme ] (accessed Dec 2014).
40. PloS. The case for open access. [http://www.plos.org/about/open-access ] (accessed June 2013).
41. Editorial. Best tests for candidates. Nature. 2008;451:605-6.
42. Purcell GP, Donovan SL, Davidoff F. Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper. JAMA. 1998;280:227-8.
43. Roberts JC, Fletcher RH, Fletcher SW. Effects of peer review and editing on the readability of articles published in Annals of Internal Medicine. JAMA. 1994;272:119-21.
44. Dickersin K, Ssemanda E, Mansell C, Rennie D. What do the JAMA editors say when they discuss manuscripts that they are considering for publication? Developing a schema for classifying the content of editorial discussion. BMC Med Res Methodol. 2007;7:44.
45. Hamm MP, Scott SD, Klassen TP, Moher D, Hartling L. Do health care institutions value research? A mixed methods study of barriers and facilitators to methodological rigor in pediatric randomized trials. BMC Med Res Methodol. 2012;12:158.
46. Ziebland S, Featherstone K, Snowdon C, Barker K, Frost H, Fairbank J. Does it matter if clinicians recruiting for a trial don't understand what the trial is really about? Qualitative study of surgeons' experiences of participation in a pragmatic multi-centre RCT. Trials. 2007;8:4.
47. Steneck NH, Bulger RE. The history, purpose, and future of instruction in the responsible conduct of research. Acad Med. 2007;82:829-34.
48. C.R.N. [http://www.crncc.nihr.ac.uk ]
49. Clinical Trials Toolkit. [ct-toolkit.ac.uk/, http://www.ct-toolkit.ac.uk ]
50. UK Trial Managers' Network. [tmn.ac.uk/guide.htm, http://www.tmn.ac.uk/guide.htm ]
51. NIHR. A guide to efficient trial management. In: Trials Managers' Network. The Fourth Edition (2014) of the Guide to Efficient Trial Management. University of Southampton Science Park, Southampton, UK: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House; 2014.
52. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290:516-23.
53. Abbasi K. Compulsory registration of clinical trials. BMJ. 2004;329:637-8.
54. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
55. PRISMA statement. [http://www.prisma-statement.org ]
56. Jones G, Abbasi K. Trial protocols at the BMJ. BMJ. 2004;329:1360.